Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma

Abstract Background With the development of the economy, the number of obese patients has been increasing annually worldwide. The proportion of asthma patients associated with obesity is also gradually rising. However, the pathogenesis of obesity-related asthma remains incompletely understood, and c...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiannan Lin, Shuwen Lu, Xiaoyu Zhao
Format: Article
Language:English
Published: BMC 2025-02-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-025-00376-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571596685967360
author Jiannan Lin
Shuwen Lu
Xiaoyu Zhao
author_facet Jiannan Lin
Shuwen Lu
Xiaoyu Zhao
author_sort Jiannan Lin
collection DOAJ
description Abstract Background With the development of the economy, the number of obese patients has been increasing annually worldwide. The proportion of asthma patients associated with obesity is also gradually rising. However, the pathogenesis of obesity-related asthma remains incompletely understood, and conventional pharmacological treatments generally show limited efficacy. Objective This study aims to explore the causal relationship between obesity and allergic asthma, elucidate the pathogenesis of obesity-related asthma, and identify the plasma proteins involved in its development, providing new insights for clinical interventions. Methods In this study, we employed a two-step approach for mediation Mendelian randomization (MR) analysis, utilizing stringent selection criteria to identify instrumental variables (IVs). This approach was used to assess the causal impact of obesity on allergic asthma and to validate the plasma proteins identified as mediating factors. We further explored the functions and enriched pathways of the mediating proteins using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Finally, we conducted drug-targeted MR analysis to evaluate the potential of each mediator plasma proteins as a drug target gene. If significant heterogeneity remained among the IVs, we applied the weighted median method as the primary analytical tool. Otherwise, we utilized the inverse variance weighted (IVW) method as the main analytical approach. Additionally, we conducted various sensitivity analyses and statistical tests to further illustrate the robustness of the observed associations. Results The research findings indicate a causal relationship between obesity and allergic asthma. Plasma proteins such as TPST1, ROR1, and DAPK1 mediate this relationship, with TPST1 accounting for over 10% of the mediation effect. GO and KEGG analyses show that the genes corresponding to these mediator proteins are primarily enriched in pathways related to responses to stimuli, carbohydrate synthesis and metabolism, regulation of certain protein activities, and synaptic connections. The drug-targeted MR analysis suggests that SIGLEC12, BOLA1, HOMER2, and TPST1 all have the potential to be drug target genes. Conclusion This study suggests that obese patients defined by BMI may promote the development of allergic asthma by influencing the expression of plasma proteins such as TPST1, ROR1, and DAPK1. Furthermore, some of these plasma proteins, including TPST1, could potentially serve as therapeutic targets for treating allergic asthma in these patients. However, further research is needed to explore their therapeutic potential and the mechanisms underlying their effects. Clinical trial number Not applicable.
format Article
id doaj-art-89699d9bf44e4efc8bec1e5aaeb23ace
institution Kabale University
issn 1601-5223
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series Hereditas
spelling doaj-art-89699d9bf44e4efc8bec1e5aaeb23ace2025-02-02T12:27:38ZengBMCHereditas1601-52232025-02-01162111010.1186/s41065-025-00376-wMediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthmaJiannan Lin0Shuwen Lu1Xiaoyu Zhao2Department of Pediatrics, Jiaxing Second HospitalDepartment of Pediatrics, Jiaxing Second HospitalDepartment of Pediatrics, Jiaxing Second HospitalAbstract Background With the development of the economy, the number of obese patients has been increasing annually worldwide. The proportion of asthma patients associated with obesity is also gradually rising. However, the pathogenesis of obesity-related asthma remains incompletely understood, and conventional pharmacological treatments generally show limited efficacy. Objective This study aims to explore the causal relationship between obesity and allergic asthma, elucidate the pathogenesis of obesity-related asthma, and identify the plasma proteins involved in its development, providing new insights for clinical interventions. Methods In this study, we employed a two-step approach for mediation Mendelian randomization (MR) analysis, utilizing stringent selection criteria to identify instrumental variables (IVs). This approach was used to assess the causal impact of obesity on allergic asthma and to validate the plasma proteins identified as mediating factors. We further explored the functions and enriched pathways of the mediating proteins using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Finally, we conducted drug-targeted MR analysis to evaluate the potential of each mediator plasma proteins as a drug target gene. If significant heterogeneity remained among the IVs, we applied the weighted median method as the primary analytical tool. Otherwise, we utilized the inverse variance weighted (IVW) method as the main analytical approach. Additionally, we conducted various sensitivity analyses and statistical tests to further illustrate the robustness of the observed associations. Results The research findings indicate a causal relationship between obesity and allergic asthma. Plasma proteins such as TPST1, ROR1, and DAPK1 mediate this relationship, with TPST1 accounting for over 10% of the mediation effect. GO and KEGG analyses show that the genes corresponding to these mediator proteins are primarily enriched in pathways related to responses to stimuli, carbohydrate synthesis and metabolism, regulation of certain protein activities, and synaptic connections. The drug-targeted MR analysis suggests that SIGLEC12, BOLA1, HOMER2, and TPST1 all have the potential to be drug target genes. Conclusion This study suggests that obese patients defined by BMI may promote the development of allergic asthma by influencing the expression of plasma proteins such as TPST1, ROR1, and DAPK1. Furthermore, some of these plasma proteins, including TPST1, could potentially serve as therapeutic targets for treating allergic asthma in these patients. However, further research is needed to explore their therapeutic potential and the mechanisms underlying their effects. Clinical trial number Not applicable.https://doi.org/10.1186/s41065-025-00376-wAllergic asthmaObesity-related asthmaPlasma proteinsMendelian randomization analysis
spellingShingle Jiannan Lin
Shuwen Lu
Xiaoyu Zhao
Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma
Hereditas
Allergic asthma
Obesity-related asthma
Plasma proteins
Mendelian randomization analysis
title Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma
title_full Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma
title_fullStr Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma
title_full_unstemmed Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma
title_short Mediating Mendelian randomization in the proteome identified potential drug targets for obesity-related allergic asthma
title_sort mediating mendelian randomization in the proteome identified potential drug targets for obesity related allergic asthma
topic Allergic asthma
Obesity-related asthma
Plasma proteins
Mendelian randomization analysis
url https://doi.org/10.1186/s41065-025-00376-w
work_keys_str_mv AT jiannanlin mediatingmendelianrandomizationintheproteomeidentifiedpotentialdrugtargetsforobesityrelatedallergicasthma
AT shuwenlu mediatingmendelianrandomizationintheproteomeidentifiedpotentialdrugtargetsforobesityrelatedallergicasthma
AT xiaoyuzhao mediatingmendelianrandomizationintheproteomeidentifiedpotentialdrugtargetsforobesityrelatedallergicasthma